Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037752 · ClinicalTrials.gov registry record · NA
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT00037752 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 436 participants.
The verdict
NCT00037752, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
Interventions
- DRUG Sibutramine
- BEHAVIORAL Behavioral Smoking Cessation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00037752
The ClinicalTrials.gov registry entry for NCT00037752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sibutramine is the first listed.
NCT00037752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00037752 about?
NCT00037752 is a clinical study titled "Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates". The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
What is the current status of trial NCT00037752?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2002-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00037752?
The interventions under investigation include: Sibutramine (DRUG), Behavioral Smoking Cessation Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00037752?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.